‘The role of protein tyrosine phosphatase in malignancy is still an under-explored area. Our study shows that receptor proteins tyrosine phosphatase T regulates a significant signaling pathway that is critical in cancer development. This identification allows new approaches to pharmacological styles and facilitate alternative approaches for cancer treatment’, said Wang. With over 52,000 deaths each full year, colon and rectal tumor is the second leading reason behind cancer death in the United States. Colon and rectal cancers begin in the digestive tract and may start in a number of different areas of the GI system which take years to progress.The experts are suffering from a therapy that runs on the patient’s bloodstream to grow unique white bloodstream cells that identify and battle infected cancer cells. The full total results of the study have already been published in the journal Cancer Research. The team of researchers from the Queensland Institute of Medical Analysis and The University of Hong Kong Li Ka Shing Faculty of Medication studied the consequences of bloodstream cell therapy on sufferers with nasopharyngeal carcinoma, a kind of throat cancers.